A study published in Blood Advances found that diabetes is associated with poorer survival rates in white patients with multiple myeloma, but not Black patients. Researchers believe higher insulin levels may accelerate cancer growth.
Researchers found higher 5-year survival rates among Kaiser Permanente patients compared to National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) estimates. Improved screening rates, cancer treatment pathways, and coordinated care may have contributed to these higher survival rates.
Research reveals strong associations between oral health and survival among people diagnosed with head and neck cancer, with better oral health linked to increased survival. Frequent dental visits were found to be associated with earlier cancer diagnosis and less deadly disease stages.
A new study by North Carolina State University researchers found that artificial light at night links with lower survival for two backyard bird species, the gray catbird and house wren. The study used data from a citizen-science program to investigate how light pollution affects birds' survival rates.
Researchers found that individuals exposed to wildfires within a year of lung cancer surgery had significantly lower overall survival rates compared to those not exposed. The closer the exposure occurred to the surgery, the worse the survival rate, with patients exposed 3-6 months after surgery facing a 48% decrease in survival chances.
A new study shows that newborn screening for severe combined immunodeficiency disease (SCID) has significantly increased the survival rate of children after bone marrow transplantation from 73% to 87%. Children diagnosed at birth have a 92.5% survival rate without infection, while those diagnosed later have lower rates.
Researchers developed outcome indicators to measure health issues in children with cancer, allowing for improvement in care and treatment. The indicators consider physical, psychosocial, and neurocognitive outcomes, providing a clear and comparable measurement of quality of survival.
Fruquintinib has shown statistically significant improvement in overall survival and progression-free survival rates for patients with metastatic colorectal cancer. The median survival rate was 7.4 months, with a 34% reduction in death compared to the placebo group.
Researchers at Niigata University developed a machine-learning model to predict the age of onset for spinocerebellar degeneration diseases like SCA3 and DRPLA. The model achieved higher prediction accuracy than traditional parametric survival analyses, making it a valuable tool for genetic counseling.
Climate change affects giraffe populations differently than expected, with higher temperatures positively affecting adult survival but rainier wet seasons negatively impacting both adults and calves. Heavy rains increase parasites and reduce nutritional value of vegetation, further threatening giraffe survival.
Researchers discovered that tumor mutation burden is a fundamental predictor of survival, independent of clinical presentation metrics. Survival was better at both low and high extremes of mutation burden, contradicting previous assumptions about the relationship between mutation burden and survivability.
A Phase III trial found that axicabtagene ciloleucel (axi-cel) significantly improved overall survival and progression-free survival in patients with early relapsed or refractory large B-cell lymphoma, compared to standard therapy. The estimated four-year survival rate was 54.6% with axi-cel.
A study investigated the effect of cancer patients' location during their final hours on survival. The results showed that patients who received treatment and care at home had longer survival times compared to those in palliative care wards, especially when prognosis was expected in months or weeks.
A new study from the USC Norris Comprehensive Cancer Center found that immigrant adults with liver cancer have a significantly higher five-year survival rate compared to those born in the US. The study identified disparities in survival rates across different racial and ethnic groups, with immigrants demonstrating better outcomes.
A new study found that quitting smoking before a lung cancer diagnosis is associated with higher survival rates. Former smokers who stopped smoking years before their diagnosis had significantly longer survival than current and former smokers diagnosed with non-small cell lung cancer.
The NRG Oncology combined trial results indicate that pathologic complete response (pCR) is associated with improved survival outcomes for patients with localized soft tissue sarcoma. pCR can be used as a prognostic factor for clinical outcomes in future STS research, with patients achieving higher overall and disease-free survival rates.
Research shows that young black rockfish grown faster during a marine heat wave, while also experiencing varying levels of survival. Moderate growth rates and sufficient food led to the highest survival rates.
Researchers at City of Hope identified a previously unknown mechanism by which interleukin-15 (IL-15) interacts with XBP1s to boost natural killer cells' survival and anti-tumor immunity. This finding suggests a promising therapeutic approach for future cancer treatments.
The IUCN Species Survival Commission has recognized two iconic Chicago institutions as Centers for Species Survival, elevating the region's role in biodiversity conservation. Shedd Aquarium and The Morton Arboretum will collaborate on projects highlighting aquatic and terrestrial linkages in Central American biodiversity hotspots.
A new AI model developed at the University of British Columbia accurately predicts cancer patient survival using natural language processing to analyze oncologist notes. The model shows over 80% accuracy in predicting six-month, 36-month and 60-month survival rates.
A phase 3 trial found that adding nab-paclitaxel to a standard gemcitabine plus cisplatin regimen did not significantly extend median overall survival for patients with advanced biliary tract cancers, but provided benefits for subsets of patients. The treatment also showed improved response rates and progression-free survival times.
A Phase 3 clinical trial has shown that a four-drug chemotherapy regimen significantly increases overall survival and progression-free survival in patients with stage 4 pancreatic ductal adenocarcinoma. The study's results suggest that this more aggressive treatment approach may be considered for eligible patients.
A large study found that Medicaid expansion under the Affordable Care Act leads to better survival outcomes for young adults aged 18-39 newly diagnosed with cancer. The research showed a significant increase in two-year survival among young adults of Hispanic ethnicity or non-Hispanic Black race.
A retrospective study found that multidisciplinary care for ALS significantly decreases multiple emergency hospitalizations and improves survival rates. The study compared patients with ALS treated at a multidisciplinary clinic versus a traditional General Neurology Clinic and showed improved outcomes.
A new clinical trial has found that chemotherapy before surgery significantly improves 1-year survival rates for patients with borderline resectable pancreatic cancer. The study, led by the University of Liverpool, compared immediate surgery with short-course neoadjuvant therapy and found a significant survival benefit.
A recent study presented at the American Heart Association's Resuscitation Science Symposium 2022 found that ICU evaluations prior to cardiac arrest improved survival rates by 15% among Black adults. This study analyzed data from over 28,000 adults who experienced cardiac arrest between 2000 and 2021.
Survival rates for in-hospital pediatric cardiac arrest events have increased significantly between 2000 and 2021. Children with a history of cardiovascular disease showed slower improvement in survival rates compared to those without a history of CVD.
Researchers confirm that turtles rehabilitated in the aftermath of the Kalamazoo River oil spill had high long-term survival rates, with up to 11 years post-spill showing nearly imperceptible differences in monthly survival probability. The study's findings suggest that rehabilitation efforts increased the monthly survival probability ...
A recent clinical trial found that patients with advanced melanoma who received immunotherapy first had a 20% higher two-year overall survival rate compared to those who initially got targeted therapies. The study also showed improved progression-free survival rates for those on immunotherapy.
A recent study has found that vitamin D deficiency is associated with lower overall survival rates in melanoma patients. The research, presented at the European Academy of Dermatology and Venereology Congress, suggests that vitamin D levels play a significant role in determining patient outcomes.
Cancer patients in rural areas experience higher mortality rates and are more likely to miss radiation appointments, leading to poorer overall survival. The study suggests that targeted support programs like patient navigation can help reduce disparities in cancer care.
The KEYNOTE-604 study shows that pembrolizumab-based combination with etoposide and platinum significantly improves progression-free survival and overall survival in patients with previously untreated ES-SCLC. Long-term follow-up data also reveal durable responses and manageable safety profiles.
The IMpower010 trial showed an overall survival trend in favor of atezolizumab in the PD-L1 TC ≥1% stage II-IIIA population, with a clinically meaningful improvement observed across most subgroups. The study found no separation for the ITT population or all-randomized, stage II–IIIA populations.
A phase 3 trial showed sugemalimab improved progression-free survival (PFS) by 69% compared to placebo, with a median PFS of 10.5 months. Overall survival (OS) data also suggested a trend towards benefit favoring sugemalimab.
Researchers from Mayo Clinic Comprehensive Cancer Center found that adding brentuximab vedotin to standard chemotherapy treatment improves overall survival in patients with Hodgkin Lymphoma. The study showed that the drug has a positive impact on overall survival, regardless of other treatments administered later in the course of care.
Researchers at Boston University School of Medicine found that high-dose chemotherapy and autologous stem cell transplantation can produce prolonged survival in patients with AL amyloidosis. The study developed a predictive score to assess event-free survival, which showed improved safety and effectiveness for selected patients.
A new report by the American Cancer Society shows individuals without health insurance coverage were more likely to be diagnosed with late-stage cancer and have worse survival rates. Uninsured individuals diagnosed with Stage I disease had worse survival rates for six cancers compared to those with private health insurance.
A recent study of over 5,000 women found that having a baby after breast cancer diagnosis does not negatively impact survival rates. Women who had hormone-receptor positive breast cancer and became mothers showed similar or increased survival compared to those without children.
A study published in the Journal of Clinical Oncology found that biochemical failure is not a reliable surrogate endpoint for overall survival in patients with recurrent prostate cancer. The researchers recommend considering metastasis-free survival (MFS) as the best surrogate endpoint for overall survival in this population.
A new study found that specific gene mutations, such as LRRK2 and PRKN, may prolong survival time in Parkinson's patients, while SNCA and GBA mutations may shorten it. This could lead to more personalized treatment plans for patients with these genetic variants.
A Phase II study found that immunotherapy before surgery improved median progression-free survival and overall survival for undifferentiated pleomorphic sarcoma and recurrent dedifferentiated liposarcoma patients. The treatment also showed an association between intratumoral B-cell receptor repertoire and survival.
A new study has identified persistent racial and ethnic disparities in five-year survival rates for younger adults with colorectal cancer. White patients had a higher five-year relative survival rate compared to Black, Hispanic, and Asian patients, regardless of disease stage.
A study of early-onset colon cancer found that five-year survival rates remained lower for Blacks and Hispanics compared to Whites, despite improvements in White survival over a 20-year span. The disparities persisted even among younger adults with localized disease.
Patients with stage II/III esophageal cancer who received delayed surgery had a relative survival rate that was almost half that of patients who underwent early surgery. Early-stage cancer patients did not experience significant differences in survival rates between those who received immediate versus delayed surgery.
A retrospective study found that higher coronary artery calcium score, higher pulmonary artery-to-aorta ratio, and lower thoracic skeletal muscle index independently predicted worse overall survival. The PA-to-aorta ratio was the most important predictor of overall survival.
A study published in Scientific Reports found that ARS-developed Pol-line honey bees have a significantly higher winter survival rate than standard honey bees, with rates of 62.5% and 3%, respectively. Additionally, Pol-line colonies showed lower levels of three major viruses commonly transmitted by Varroa mites.
A new study published in The Journal of Wildlife Management found that perennial grassland cover affects duck nest survival differently depending on its dominance as a landcover type. In the Prairie Pothole Region, intermediate levels of perennial cover (30–60%) showed no additional benefits for nest survival.
A new study found significant improvement in survival rates of extremely pre-term babies born at 22 and 23 weeks. The study, which examined data from 2013-2018, showed a considerable increase in survival rates compared to previous studies, with survival rates reaching 30.0% at 22 weeks and 55.8% at 23 weeks.
A new study found that non-medical first responders, such as police and fire departments, are associated with higher cardiac arrest survival rates. They initiated CPR in 31.8% of incidents and AED use in 6.1% of cases, leading to significantly improved chances of survival and hospital discharge.
A comprehensive study analyzing international literature on wildlife rehabilitation found that human activity is a significant factor influencing outcomes. The study identified five key categories of factors impacting survival outcomes for rescued wildlife, highlighting the need for rehabilitators to mitigate threats and address these ...
A randomized Phase III trial showed a significant overall survival benefit with ribociclib plus endocrine therapy for postmenopausal patients with HR+ and HER2- metastatic breast cancer. The median survival was 63.9 months, and the six-year survival rate was 44.2%, compared to 51.4 months and 32% for placebo.
Researchers at the University of Illinois Chicago have developed a compound that may offer hope for pancreatic cancer treatment. The experimental compound, XP-524, has been shown to more than double the average survival time for mice with pancreatic cancer when combined with immunotherapy.
A phase II clinical trial at St. Jude Children's Research Hospital found significantly higher survival rates for children with high-risk neuroblastoma treated with chemoimmunotherapy and the humanized monoclonal antibody hu14.18K322A, resulting in a three-year disease-free survival rate of 73.7% and an overall survival rate of 86%.
A Phase II study shows that combination treatment with nivolumab and ipilimumab improves overall survival in patients with asymptomatic melanoma brain metastases, with an overall survival rate of 71.9% at three years. The treatment demonstrates durable responses, even in symptomatic patients.
According to experts, half of patients with two common subtypes of advanced breast cancer may live for five years or longer. The new guidelines also aim to improve treatment options for triple-negative breast cancer patients.
A multi-center study demonstrated improved overall survival and quality of life for inoperable pancreatic cancer patients treated with MRIdian SMART, with a median survival of 26 months. The treatment showed low rates of major adverse events and was more effective than standard radiation therapy.
A study of semi-captive Asian elephants found that calves raised with older sisters had higher long-term survival rates and reproduced earlier than those without a sibling. In contrast, male elephants raised with older sisters experienced lower survival but increased body weight.
A novel combination of abiraterone acetate and prednisolone has been shown to prolong survival in patients with hormone/castration-sensitive prostate cancer. Studies PEACE-1 and STAMPEDE found that the addition of these drugs to standard therapy lengthened survival compared to standard therapy alone.
The MONALEESA-2 trial found that adding a CDK 4/6 inhibitor to first-line hormonal treatment prolongs survival by one year for postmenopausal women with HR-positive, HER2-negative advanced breast cancer. The combination of endocrine therapy and the CDK 4/6 inhibitor ribociclib also extends progression-free survival.
A Phase III trial showed a significant overall survival benefit of 63.9 months with ribociclib, compared to 51.4 months with hormone therapy alone. The estimated six-year survival rate was 44.2% with ribociclib, compared to 32% for placebo.